Lipocalin-2 Regulates Osteocyte Ferroptosis and Osteocyte-Osteoblast Crosstalk via Wnt Signaling to Control Bone Formation
Abstract
Osteoporosis
is
a
multifactorial
disease,
and
emerging
evidence
suggests
that
iron
overload
contributes
to
its
progression.
Here,
we
identify
Lipocalin-2
(LCN2),
cytokine
secreted
by
bone
cells
with
endocrine
effects
on
other
tissues,
as
local
regulator
of
osteocyte
metabolism
mediator
skeletal
deterioration.
Our
findings
reveal
LCN2
promotes
accumulation,
mitochondrial
dysfunction,
ferroptosis
in
osteocytes
process
dependent
receptor
SLC22A17.
Genetic
ablation
Lcn2
(Dmp1 -Cre;
Lcn2 fl/fl )
mitigates
their
ferroptotic
vulnerability
preserving
integrity
limiting
overload.
Remarkably,
deletion
enhances
dendricity
lacunocanalicular
network,
supporting
function
remodeling.
Mechanistically,
demonstrate
decreases
DKK1
SOST
expression
bone,
leading
increased
Wnt/β-catenin
signaling
osteoblast-driven
formation.
Using
vitro
vivo
approaches,
establish
the
LCN2-SLC22A17
axis
key
pathway
linking
homeostasis,
These
provide
insight
into
previously
unrecognized
mechanism
underlying
iron-driven
loss
suggest
targeting
could
offer
therapeutic
potential
for
osteoporosis.
Published: April 29, 2025
Language: Английский